Key result
Older age is linked to ~1% higher odds of poliovirus seronegativity per year.
Why the study?
Poliovirus immunity varies across population groups and serotypes, and serological evidence can reveal immunity gaps not shown by vaccination coverage alone.
Cross-Sectional (n=5,859)
In a population-based US cohort, increasing age is the most consistent predictor of poliovirus Type 3 seronegativity, while the addition of routine biological variables provides only modest improvements in machine learning predictive performance.
Answers are grounded in this paper and cite their sources.
Age independently predicts Type 3 seronegativity; hypothesis-generating for modest biological-marker gains in machine-learning models.
Poliovirus immunity can differ across population groups and serotypes. Serological evidence can reveal immunity gaps which are not shown by vaccination coverage alone. This study examined demographic and biological factors connected with poliovirus seronegativity. The study aimed to identify factors associated with poliovirus neutralising-antibody seronegativity. It also assessed whether biological variables improved prediction beyond demographic factors. A cross-sectional method is conducted using NHANES 2017- March 2020 data. Five datasets are linked using the participant sequence number and the final analysis included 5859 participants aged 6-59 years old. Type 3 seronegativity is the primary basic outcome. Type 1, Type 2 and any-serotype seronegativity are secondary outcomes. Demographic, anthropometric, haematological and inflammatory variables are examined. Survey-weighted logistic regression derived adjusted associations. Explainable machine-learning models compared demographic, biological and combined predictors. Type 3 showed the highest seronegativity among individual serotypes. Older age is the clearest independent factor associated with Type 3 seronegativity. Differences are also observed for BMI, neutrophils, platelets, haemoglobin, hs-CRP and PLR. Most biological measures are not independently associated after adjustment. The combined machine-learning model achieved the strongest discrimination. It also showed the highest sensitivity for identifying seronegative participants. However, specificity and overall accuracy remained limited. Age is the dominant predictor in the decision-tree analysis. PLR shows a smaller additional contribution. Poliovirus seronegativity remains an important population immunity concern. Age appears to be the most consistent associated factor. Biological variables provide some additional predictive information when combined with demographic characteristics. However, their overall predictive contribution remains modest. Explainable machine learning can help identify population profiles linked with seronegativity. Further longitudinal studies are needed to examine antibody persistence and changes over time.
No takes yet. Share an insight, caveat, or question.
Paul et al. (2026) conducted a cross-sectional in Poliovirus neutralizing antibody seronegativity (n=5,859). Age (per additional year) was evaluated on Type 3 poliovirus neutralizing-antibody seronegativity (OR 1.015, 95% CI 1.006-1.024, p=0.009). Each additional year of age independently increased the odds of Type 3 poliovirus seronegativity, while biological markers added only modest predictive value in machine learning models.
Synapse has enriched 8 closely related papers on similar clinical questions. Consider them for comparative context: